398 related articles for article (PubMed ID: 27056183)
1. Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study.
Farhan S; Freynhofer MK; Brozovic I; Bruno V; Vogel B; Tentzeris I; Baumgartner-Parzer S; Huber K; Kautzky-Willer A
Cardiovasc Diabetol; 2016 Apr; 15():60. PubMed ID: 27056183
[TBL] [Abstract][Full Text] [Related]
2. Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary intervention.
Loncar G; Barthelemy O; Berman E; Kerneis M; Petroni T; Payot L; Choussat R; Silvain J; Collet JP; Helft G; Montalescot G; Le Feuvre C
Arch Cardiovasc Dis; 2015 Nov; 108(11):554-62. PubMed ID: 26184868
[TBL] [Abstract][Full Text] [Related]
3. Relation of growth-differentiation factor 15 to left ventricular remodeling in ST-segment elevation myocardial infarction.
Dominguez-Rodriguez A; Abreu-Gonzalez P; Avanzas P
Am J Cardiol; 2011 Oct; 108(7):955-8. PubMed ID: 21784389
[TBL] [Abstract][Full Text] [Related]
4. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
5. GDF-15 and TRAIL-R2 are powerful predictors of long-term mortality in patients with acute myocardial infarction.
Skau E; Henriksen E; Wagner P; Hedberg P; Siegbahn A; Leppert J
Eur J Prev Cardiol; 2017 Oct; 24(15):1576-1583. PubMed ID: 28762762
[TBL] [Abstract][Full Text] [Related]
6. Growth-differentiation factor 15 for long-term prognostication in patients with non-ST-elevation acute coronary syndrome: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy.
Damman P; Kempf T; Windhausen F; van Straalen JP; Guba-Quint A; Fischer J; Tijssen JG; Wollert KC; de Winter RJ; Hirsch A;
Int J Cardiol; 2014 Mar; 172(2):356-63. PubMed ID: 24502880
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome.
Wollert KC; Kempf T; Peter T; Olofsson S; James S; Johnston N; Lindahl B; Horn-Wichmann R; Brabant G; Simoons ML; Armstrong PW; Califf RM; Drexler H; Wallentin L
Circulation; 2007 Feb; 115(8):962-71. PubMed ID: 17283261
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of Elevated Levels of Growth Differentiation Factor-15 to Classify Patients With Acute Coronary Syndrome Having Percutaneous Coronary Intervention Who Would Benefit from High-Dose Statin Therapy.
Tentzeris I; Farhan S; Freynhofer MK; Rohla M; Jarai R; Vogel B; Baumgartner-Parzer S; Nürnberg M; Geppert A; Wessely E; Wojta J; Huber K; Kautzky-Willer A
Am J Cardiol; 2017 Sep; 120(5):747-752. PubMed ID: 28734463
[TBL] [Abstract][Full Text] [Related]
9. Multibiomarker analysis in patients with acute myocardial infarction.
Schernthaner C; Lichtenauer M; Wernly B; Paar V; Pistulli R; Rohm I; Jung C; Figulla HR; Yilmaz A; Cadamuro J; Haschke-Becher E; Pernow J; Schulze PC; Hoppe UC; Kretzschmar D
Eur J Clin Invest; 2017 Sep; 47(9):638-648. PubMed ID: 28683166
[TBL] [Abstract][Full Text] [Related]
10. Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome.
Wollert KC; Kempf T; Lagerqvist B; Lindahl B; Olofsson S; Allhoff T; Peter T; Siegbahn A; Venge P; Drexler H; Wallentin L
Circulation; 2007 Oct; 116(14):1540-8. PubMed ID: 17848615
[TBL] [Abstract][Full Text] [Related]
11. Growth differentiation factor 15 and cardiovascular events in patients with stable ischemic heart disease (The Heart and Soul Study).
Schopfer DW; Ku IA; Regan M; Whooley MA
Am Heart J; 2014 Feb; 167(2):186-192.e1. PubMed ID: 24439979
[TBL] [Abstract][Full Text] [Related]
12. Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial.
Fuernau G; Poenisch C; Eitel I; de Waha S; Desch S; Schuler G; Adams V; Werdan K; Zeymer U; Thiele H
Eur J Heart Fail; 2014 Aug; 16(8):880-7. PubMed ID: 24903195
[TBL] [Abstract][Full Text] [Related]
13. Comparison of plaque characteristics in narrowings with ST-elevation myocardial infarction (STEMI), non-STEMI/unstable angina pectoris and stable coronary artery disease (from the ADAPT-DES IVUS Substudy).
Dong L; Mintz GS; Witzenbichler B; Metzger DC; Rinaldi MJ; Duffy PL; Weisz G; Stuckey TD; Brodie BR; Yun KH; Xu K; Kirtane AJ; Stone GW; Maehara A
Am J Cardiol; 2015 Apr; 115(7):860-6. PubMed ID: 25661569
[TBL] [Abstract][Full Text] [Related]
14. Increased Serum Level of Growth Differentiation Factor 15 (GDF-15) is Associated with Coronary Artery Disease.
Wang X; Chen LL; Zhang Q
Cardiovasc Ther; 2016 Jun; 34(3):138-43. PubMed ID: 26996787
[TBL] [Abstract][Full Text] [Related]
15. Growth differentiation factor-15 levels and the risk of contrast induced acute kidney injury in acute myocardial infarction patients treated invasively: A propensity-score match analysis.
Sun L; Zhou X; Jiang J; Zang X; Chen X; Li H; Cao H; Wang Q
PLoS One; 2018; 13(3):e0194152. PubMed ID: 29529072
[TBL] [Abstract][Full Text] [Related]
16. Acute-phase dynamics and prognostic value of growth differentiation factor-15 in ST-elevation myocardial infarction.
Rueda F; Lupón J; García-García C; Cediel G; Aranda Nevado MC; Serra Gregori J; Labata C; Oliveras T; Ferrer M; de Diego O; Serra J; Revuelta López E; Bayés-Genís A
Clin Chem Lab Med; 2019 Jun; 57(7):1093-1101. PubMed ID: 30707681
[TBL] [Abstract][Full Text] [Related]
17. Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.
Farzaneh-Far A; Phillips HR; Shaw LK; Starr AZ; Fiuzat M; O'Connor CM; Sastry A; Shaw LJ; Borges-Neto S
JACC Cardiovasc Imaging; 2012 Jul; 5(7):715-24. PubMed ID: 22789940
[TBL] [Abstract][Full Text] [Related]
18. The association between growth differentiation factor 15 and presence and severity of coronary atherosclerosis.
Ozdemir E; Stavileci B; Ozdemir B; Aksoy FA; Kahraman S; Colakoglu Gevher CZ; Ziyrek M; Dogan A
Adv Med Sci; 2024 Mar; 69(1):56-60. PubMed ID: 38368744
[TBL] [Abstract][Full Text] [Related]
19. Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) Trials.
Damman P; van Geloven N; Wallentin L; Lagerqvist B; Fox KA; Clayton T; Pocock SJ; Hirsch A; Windhausen F; Tijssen JG; de Winter RJ
JACC Cardiovasc Interv; 2012 Feb; 5(2):191-9. PubMed ID: 22361604
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry.
Steg PG; Greenlaw N; Tendera M; Tardif JC; Ferrari R; Al-Zaibag M; Dorian P; Hu D; Shalnova S; Sokn FJ; Ford I; Fox KM;
JAMA Intern Med; 2014 Oct; 174(10):1651-9. PubMed ID: 25110899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
